U.S. market Open. Closes in 3 hours

BNTX | BioNTech SE Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for BNTX we got that it has strong fundamentals where Valuation is considered to be undervalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is confidently strong.

Valuation (74%)

Company Industry
P/E Ratio (TTM) -49.26 -23.05
PEG Ratio (TTM) 0.09 15.47
P/S Ratio (TTM) 9.31 49.46
P/B Ratio (TTM) 1.31 18.87
P/FCF Ratio (TTM) 10.58 -3.27
Price to 5YR AVG Earnings Ratio 6.78 -3.55
Price to 5YR AVG FCF Ratio 7.43 -9.37

Profitability (25%)

Company Industry
ROA (TTM) -2.29% -5.14%
ROE (TTM) -2.57% 16.69%
Net Profit Margin (TTM) -18.89% -1,583.93%
ROIC 5YR AVG 108.46% 15.15%

Growth (100%)

4QTR AVG 3YR AVG 5YR AVG
EPS 7.26% 24,192.03% 14,494.57%
Revenue 95.18% 1,387.91% 815.40%
Net Income 10.75% 22,483.06% 13,470.14%
Cash Flow 100.94% 2,185.02% 1,584.14%

Health (84%)

Company Industry
Current Ratio (TTM) 7.54 6.13
Quick Ratio (TTM) 7.40 5.85
D/E Ratio (TTM) 0.01 -15.81
Interest Coverage (TTM) -18.57 -1.57
Piotroski F-Score 7 5
Altman Z-Score 7.25 14.12
LTL to 5YR AVG FCF 0.05 0.17
Shares Outstanding Growth 5YR AVG 1.36% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙